SCHEMBL2494490

SCHEMBL2494490

COc1ccc(C)cc1C1(Cl)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 2/20 0.46
KCNQ3 O43525 1/20 0.46
KCNQ2 O43526 1/20 0.46
KCNQ4 P56696 1/20 0.46
KCNQ5 Q9NR82 1/20 0.46
IDO1 P14902 2/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
ADAMTS5 Q9UNA0 2/20 0.41
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP8 P22894 1/20 0.40
MMP14 P50281 1/20 0.40
MMP17 Q9ULZ9 1/20 0.40
CBX7 O95931 1/20 0.40
CDYL Q9Y232 1/20 0.40
ACHE P22303 2/20 0.39
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4588923 0.87 ADAMTS5 (0.48) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL5357970 0.84 KMT2A (0.51) KCNMA1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL1795899 0.84 KMT2A (0.51) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL2493209 0.84 KCNQ3 (0.44) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL5858701 0.84 KCNMA1 (0.63) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL2497604 0.84 KMT2A (0.51) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL2496619 0.80 KCNQ3 (0.41) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL2499481 0.80 HTR7 (0.45) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL4590061 0.80 CBX7 (0.47) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL4588940 0.80 CBX7 (0.45) KCNMA1KCNQ3KCNQ2KCNQ4KCNQ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 KCNMA1 2340/4885KCNQ3 1426/4885KCNQ2 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.